RESMED INC. DL-,004/ US7611521078 /
2024-05-23 9:43:18 PM | Chg. -7.150 | Volume | Bid9:59:57 PM | Ask9:59:57 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
194.750EUR | -3.54% | 10 Turnover: 1,979.600 |
195.550Bid Size: 89 | 195.950Ask Size: 89 | 28.72 bill.EUR | - | - |
GlobeNewswire
05-23
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provid...
GlobeNewswire
05-16
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and ...
GlobeNewswire
05-16
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Dat...
GlobeNewswire
05-07
XEALTH AND STEL LIFE TEAM UP, CONNECTING PATIENT HEALTH DEVICES AND CARE TEAMS VIA CELLULAR NETWORKS
GlobeNewswire
04-10
CHILDREN’S WISCONSIN REMOTELY MONITORING PEDIATRIC PATIENTS VIA XEALTH AND LOCUS HEALTH
GlobeNewswire
03-06
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Per...
GlobeNewswire
03-05
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
GlobeNewswire
02-15
ACELYRIN, INC. Appoints Agnes Lee as Senior Vice President, Investor Relations and Corporate Communi...
GlobeNewswire
02-12
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions abo...
GlobeNewswire
02-06
Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth...